-
公开(公告)号:US07217706B2
公开(公告)日:2007-05-15
申请号:US10074020
申请日:2002-02-14
申请人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
发明人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
IPC分类号: A61K31/54 , A61K31/24 , C09D211/06 , C09D211/70 , C07C233/00
CPC分类号: C07D213/40 , A61K31/165 , A61K31/223 , A61K31/404 , A61K31/4045 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4468 , A61K31/495 , A61K31/501 , A61K31/5375 , C07C215/46 , C07C217/30 , C07C217/74 , C07C219/24 , C07C229/18 , C07C229/50 , C07C233/25 , C07C233/43 , C07C233/80 , C07C235/20 , C07C235/24 , C07C237/48 , C07C271/24 , C07C271/30 , C07C271/58 , C07C275/22 , C07C279/22 , C07C307/02 , C07C307/10 , C07C311/08 , C07C311/18 , C07C317/32 , C07C323/25 , C07C323/41 , C07C2601/06 , C07C2601/14 , C07C2602/12 , C07D209/08 , C07D209/16 , C07D211/26 , C07D213/73 , C07D213/85 , C07D233/60 , C07D235/26 , C07D277/46 , C07D295/185 , C07D401/04 , C07D417/14
摘要: This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.
摘要翻译: 本发明涉及由下式[I]表示的新的丙醇胺衍生物或其盐:其中每个符号如说明书中所定义或其盐,其具有肠选择性交感神经兴奋剂,抗溃疡性,抗胰腺炎,脂肪分解,抗尿液 失禁和抗尿频活动,其制备方法,包含其的药物组合物,以及用于预防和/或治疗本说明书中对人或动物表示的疾病的方法。
-
公开(公告)号:US06495546B1
公开(公告)日:2002-12-17
申请号:US09646878
申请日:2000-11-22
申请人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
发明人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
IPC分类号: A61K3154
CPC分类号: C07D213/40 , A61K31/165 , A61K31/223 , A61K31/404 , A61K31/4045 , A61K31/426 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4468 , A61K31/495 , A61K31/501 , A61K31/5375 , C07C215/46 , C07C217/30 , C07C217/74 , C07C219/24 , C07C229/18 , C07C229/50 , C07C233/25 , C07C233/43 , C07C233/80 , C07C235/20 , C07C235/24 , C07C237/48 , C07C271/24 , C07C271/30 , C07C271/58 , C07C275/22 , C07C279/22 , C07C307/02 , C07C307/10 , C07C311/08 , C07C311/18 , C07C317/32 , C07C323/25 , C07C323/41 , C07C2601/06 , C07C2601/14 , C07C2602/12 , C07D209/08 , C07D209/16 , C07D211/26 , C07D213/73 , C07D213/85 , C07D233/60 , C07D235/26 , C07D277/46 , C07D295/185 , C07D401/04 , C07D417/14
摘要: Propanolamine derivatives represented by the following formula (I): These derivatives may be &bgr;3 agonists and exert sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic and anti-urinary incontinence and anti-pollakiuria activities. Pharmaceutical compositions containing such propanolamine derivatives, methods for the prevention and/or treatment diseases using these propanolamine derivatives, and processes for their preparation are also described.
摘要翻译: 由下式(I)表示的丙醇胺衍生物:这些衍生物可以是β3激动剂,并且发挥拟交感神经,抗溃疡,抗胰腺炎,脂肪分解和抗尿失禁和抗尿频活性。 还描述了含有这种丙醇胺衍生物的药物组合物,使用这些丙醇胺衍生物预防和/或治疗疾病的方法及其制备方法。
-
公开(公告)号:US06635634B2
公开(公告)日:2003-10-21
申请号:US10074020
申请日:2002-02-14
申请人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
发明人: Kiyoshi Taniguchi , Minoru Sakurai , Naoaki Fujii , Kumi Hosoi , Yasuyo Tomishima , Hisashi Takasugi , Hajime Sogabe , Hirofumi Ishikawa , Naomi Hanioka
IPC分类号: A61K3154
摘要: This invention relates to new propanolamine derivatives or salts thereof represented by the following formula [I]: Wherein each symbol is as defined in the specification or salts thereof which have gut selective sympathomimetic, anti-ulcerous, anti-pancreatitis, lipolytic, anti-urinary incontinence and anti-pollakiuria activities, to processes for the preparation thereof, to a pharmaceutical composition comprising the same and to a method for the prevention and/or treatment diseases indicated in the specification to a human being or an animal.
-
-